• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经降压素是一种脂诱导的胃肠肽,与肥胖症内脏脂肪组织炎症有关。

Neurotensin Is a Lipid-Induced Gastrointestinal Peptide Associated with Visceral Adipose Tissue Inflammation in Obesity.

机构信息

Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.

Department of Medical-Surgical Sciences and Bio-Technologies, Sapienza University of Rome, 00161 Rome, Italy.

出版信息

Nutrients. 2018 Apr 23;10(4):526. doi: 10.3390/nu10040526.

DOI:10.3390/nu10040526
PMID:29690638
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5946311/
Abstract

Neurotensin (NT) is a 13-amino acid peptide localized in the neuroendocrine cells of the small intestine, which promotes fat absorption and fatty acids translocation in response to lipid ingestion. NT-knock-out mice fed with a high-fat diet are protected from obesity, fatty liver, and the development of insulin-resistance. In humans, higher plasma levels of pro-NT, which is the stable circulating precursor of NT, predict obesity, type 2 diabetes (T2D), and cardiovascular disease. In obesity, the presence of visceral adipose tissue (VAT) inflammation leads to unfavorable metabolic outcomes and is associated with the development of T2D and non-alcoholic fatty liver disease (NAFLD). In this study, we investigated the relationship between plasma pro-NT levels and the presence of VAT inflammation in biopsies from 40 morbidly obese subjects undergoing bariatric surgery. We demonstrated that higher proNT levels are significantly associated with greater macrophages infiltration, HIF-1α, WISP-1, and UNC5B expression in VAT (all < 0.01) due to the diagnosis of T2D and NAFLD. The overall results show that, in obesity, pro-NT is a biomarker of VAT inflammation and insulin-resistance. Additionally, NT may be involved in the development of dysmetabolic conditions likely mediated by increased gut fat absorption and the presence of a proinflammatory milieu in the adipose tissue.

摘要

神经降压素(NT)是一种 13 个氨基酸的肽,定位于小肠的神经内分泌细胞中,可促进脂肪吸收和脂肪酸易位,以响应脂质摄入。用高脂肪饮食喂养的神经降压素敲除小鼠可预防肥胖、脂肪肝和胰岛素抵抗的发生。在人类中,前神经降压素(pro-NT),即 NT 的稳定循环前体,其血浆水平升高可预测肥胖、2 型糖尿病(T2D)和心血管疾病。在肥胖症中,内脏脂肪组织(VAT)炎症的存在会导致不良的代谢后果,并与 T2D 和非酒精性脂肪肝(NAFLD)的发生有关。在这项研究中,我们调查了 40 名接受减肥手术的病态肥胖患者活检中血浆 pro-NT 水平与 VAT 炎症之间的关系。我们证明,由于 T2D 和 NAFLD 的诊断,更高的 proNT 水平与 VAT 中巨噬细胞浸润、HIF-1α、WISP-1 和 UNC5B 表达的增加显著相关(均 < 0.01)。总体结果表明,在肥胖症中,pro-NT 是 VAT 炎症和胰岛素抵抗的生物标志物。此外,NT 可能参与了代谢紊乱的发展,可能是通过增加肠道脂肪吸收和脂肪组织中存在促炎环境介导的。

相似文献

1
Neurotensin Is a Lipid-Induced Gastrointestinal Peptide Associated with Visceral Adipose Tissue Inflammation in Obesity.神经降压素是一种脂诱导的胃肠肽,与肥胖症内脏脂肪组织炎症有关。
Nutrients. 2018 Apr 23;10(4):526. doi: 10.3390/nu10040526.
2
Increased Plasma Proneurotensin Levels Identify NAFLD in Adults With and Without Type 2 Diabetes.血浆前神经降压素水平升高可识别 2 型糖尿病合并或不合并非酒精性脂肪性肝病的成人。
J Clin Endocrinol Metab. 2018 Jun 1;103(6):2253-2260. doi: 10.1210/jc.2017-02751.
3
Association between systemic leptin and neurotensin concentration in adult individuals with and without type 2 diabetes mellitus.成年 2 型糖尿病患者和非糖尿病患者的血清瘦素和神经降压素浓度的关系。
J Endocrinol Invest. 2018 Oct;41(10):1159-1163. doi: 10.1007/s40618-018-0845-9. Epub 2018 Feb 7.
4
An obligatory role for neurotensin in high-fat-diet-induced obesity.神经降压素在高脂饮食诱导的肥胖中起重要作用。
Nature. 2016 May 19;533(7603):411-5. doi: 10.1038/nature17662. Epub 2016 May 11.
5
Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease.脂肪组织炎症与非酒精性脂肪性肝病组织学严重程度的相关性。
Gastroenterology. 2015 Sep;149(3):635-48.e14. doi: 10.1053/j.gastro.2015.05.044. Epub 2015 May 28.
6
Effect of gastric bypass and gastric banding on proneurotensin levels in morbidly obese patients.胃旁路手术和胃束带手术对病态肥胖患者前神经降压素水平的影响。
J Clin Endocrinol Metab. 2006 Sep;91(9):3544-7. doi: 10.1210/jc.2006-0256. Epub 2006 Jun 20.
7
Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes.预测 2 型糖尿病的血清脂肪因子在皮下和内脏脂肪组织中的基因表达。
Obesity (Silver Spring). 2010 May;18(5):884-9. doi: 10.1038/oby.2009.443. Epub 2009 Dec 17.
8
Toll-like receptor 3 ablation prevented high-fat diet-induced obesity and metabolic disorder.Toll 样受体 3 缺失可预防高脂饮食诱导的肥胖和代谢紊乱。
J Nutr Biochem. 2021 Sep;95:108761. doi: 10.1016/j.jnutbio.2021.108761. Epub 2021 Jun 6.
9
Fatty acid uptake and blood flow in adipose tissue compartments of morbidly obese subjects with or without type 2 diabetes: effects of bariatric surgery.伴有或不伴有2型糖尿病的病态肥胖受试者脂肪组织区域的脂肪酸摄取和血流:减肥手术的影响
Am J Physiol Endocrinol Metab. 2017 Aug 1;313(2):E175-E182. doi: 10.1152/ajpendo.00044.2017. Epub 2017 Apr 11.
10
WISP1 is a novel adipokine linked to inflammation in obesity.WISP1 是一种新型脂肪因子,与肥胖中的炎症有关。
Diabetes. 2015 Mar;64(3):856-66. doi: 10.2337/db14-0444. Epub 2014 Oct 3.

引用本文的文献

1
Circulating Proneurotensin Levels Predict Impaired Bone Mineralisation in Postmenopausal Women With Type 2 Diabetes Mellitus.循环前神经降压素水平可预测绝经后2型糖尿病女性的骨矿化受损。
Diabetes Metab Res Rev. 2025 Jan;41(1):e70018. doi: 10.1002/dmrr.70018.
2
Association between augmented levels of the gut pro-hormone Proneurotensin and subclinical vascular damage.肠道前神经降压素水平升高与亚临床血管损伤的关系。
Sci Rep. 2024 Jul 2;14(1):15086. doi: 10.1038/s41598-024-65992-4.
3
Proneurotensin/Neuromedin N and Risk of Incident CKD and Other Kidney Outcomes in Community-Living Individuals: The REGARDS Study.

本文引用的文献

1
Increased Plasma Proneurotensin Levels Identify NAFLD in Adults With and Without Type 2 Diabetes.血浆前神经降压素水平升高可识别 2 型糖尿病合并或不合并非酒精性脂肪性肝病的成人。
J Clin Endocrinol Metab. 2018 Jun 1;103(6):2253-2260. doi: 10.1210/jc.2017-02751.
2
Association between systemic leptin and neurotensin concentration in adult individuals with and without type 2 diabetes mellitus.成年 2 型糖尿病患者和非糖尿病患者的血清瘦素和神经降压素浓度的关系。
J Endocrinol Invest. 2018 Oct;41(10):1159-1163. doi: 10.1007/s40618-018-0845-9. Epub 2018 Feb 7.
3
Loss of Action via Neurotensin-Leptin Receptor Neurons Disrupts Leptin and Ghrelin-Mediated Control of Energy Balance.
前神经降压素/神经介素N与社区居住个体发生慢性肾脏病及其他肾脏结局的风险:REGARDS研究
Kidney Med. 2024 Apr 24;6(6):100831. doi: 10.1016/j.xkme.2024.100831. eCollection 2024 Jun.
4
Reduced Lipopolysaccharide-Binding Protein (LBP) Levels Are Associated with Non-Alcoholic Fatty Liver Disease (NAFLD) and Adipose Inflammation in Human Obesity.脂多糖结合蛋白(LBP)水平降低与人类肥胖中的非酒精性脂肪性肝病(NAFLD)和脂肪炎症有关。
Int J Mol Sci. 2023 Dec 6;24(24):17174. doi: 10.3390/ijms242417174.
5
Endoplasmic reticulum stress in the adipose tissue and monocyte chemoattractant protein-1 are involved in tacrolimus-induced diabetes mellitus.内质网应激在脂肪组织和单核细胞趋化蛋白-1 中参与了他克莫司诱导的糖尿病。
Pharmacol Res Perspect. 2023 Jun;11(3):e01081. doi: 10.1002/prp2.1081.
6
Neurotensin Gene rs2234762 C>G Variant Associates with Reduced Circulating Pro-NT Levels and Predicts Lower Insulin Resistance in Overweight/Obese Children.神经降压素基因 rs2234762 C>G 变体与循环前神经降压素水平降低有关,并可预测超重/肥胖儿童的胰岛素抵抗降低。
Int J Mol Sci. 2023 Mar 30;24(7):6460. doi: 10.3390/ijms24076460.
7
New Insights in the Control of Fat Homeostasis: The Role of Neurotensin.脂肪稳态调控的新视角:神经降压素的作用。
Int J Mol Sci. 2022 Feb 17;23(4):2209. doi: 10.3390/ijms23042209.
8
Pro-neurotensin/Neuromedin N and Hypertension Risk: A Prospective Study.神经降压素前肽/神经介素 N 与高血压风险:一项前瞻性研究。
Am J Hypertens. 2022 Mar 8;35(3):281-288. doi: 10.1093/ajh/hpab166.
9
Circulating Levels of Pro-Neurotensin and Its Relationship with Nonalcoholic Steatohepatitis and Hepatic Lipid Metabolism.前神经降压素的循环水平及其与非酒精性脂肪性肝炎和肝脏脂质代谢的关系
Metabolites. 2021 Jun 10;11(6):373. doi: 10.3390/metabo11060373.
10
Neurotensin is an anti-thermogenic peptide produced by lymphatic endothelial cells.神经降压素是由淋巴管内皮细胞产生的一种抗热敏肽。
Cell Metab. 2021 Jul 6;33(7):1449-1465.e6. doi: 10.1016/j.cmet.2021.04.019. Epub 2021 May 25.
通过神经降压素-瘦素受体神经元失去作用会破坏瘦素和胃饥饿素介导的能量平衡控制。
Endocrinology. 2017 May 1;158(5):1271-1288. doi: 10.1210/en.2017-00122.
4
Adipose tissue inflammation: a cause or consequence of obesity-related insulin resistance?脂肪组织炎症:肥胖相关胰岛素抵抗的原因还是结果?
Clin Sci (Lond). 2016 Sep 1;130(18):1603-14. doi: 10.1042/CS20160005.
5
Phenotypical heterogeneity linked to adipose tissue dysfunction in patients with Type 2 diabetes.2 型糖尿病患者脂肪组织功能障碍与表型异质性相关。
Clin Sci (Lond). 2016 Oct 1;130(19):1753-62. doi: 10.1042/CS20160348. Epub 2016 Jul 25.
6
Circulating Proneurotensin Concentrations and Cardiovascular Disease Events in the Community: The Framingham Heart Study.社区中循环前神经降压素浓度与心血管疾病事件:弗雷明汉心脏研究
Arterioscler Thromb Vasc Biol. 2016 Aug;36(8):1692-7. doi: 10.1161/ATVBAHA.116.307847. Epub 2016 Jun 16.
7
An obligatory role for neurotensin in high-fat-diet-induced obesity.神经降压素在高脂饮食诱导的肥胖中起重要作用。
Nature. 2016 May 19;533(7603):411-5. doi: 10.1038/nature17662. Epub 2016 May 11.
8
Bariatric and metabolic surgery: a shift in eligibility and success criteria.减重与代谢手术:适应证和成功标准的转变。
Nat Rev Endocrinol. 2015 Aug;11(8):465-77. doi: 10.1038/nrendo.2015.84. Epub 2015 Jun 9.
9
Telmisartan attenuates the inflamed mesenteric adipose tissue in spontaneous colitis by mechanisms involving regulation of neurotensin/microRNA-155 pathway.替米沙坦通过调节神经降压素/微小 RNA-155 通路减轻自发性结肠炎中炎症性肠系膜脂肪组织的损伤。
Biochem Pharmacol. 2015 Feb 15;93(4):461-9. doi: 10.1016/j.bcp.2014.12.020. Epub 2015 Jan 8.
10
Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality.血浆前神经降压素与糖尿病、心血管疾病、乳腺癌及死亡率的关系。
JAMA. 2012 Oct 10;308(14):1469-75. doi: 10.1001/jama.2012.12998.